Neurogene Balance Sheet Health
Financial Health criteria checks 6/6
Neurogene has a total shareholder equity of $186.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $222.6M and $36.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$197.16m |
Equity | US$186.02m |
Total liabilities | US$36.55m |
Total assets | US$222.57m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: NGNE's short term assets ($200.3M) exceed its short term liabilities ($23.0M).
Long Term Liabilities: NGNE's short term assets ($200.3M) exceed its long term liabilities ($13.6M).
Debt to Equity History and Analysis
Debt Level: NGNE is debt free.
Reducing Debt: NGNE had no debt 5 years ago.
Debt Coverage: NGNE has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: NGNE has no debt, therefore coverage of interest payments is not a concern.